Access to medicines: Caught between expensive patented drugs and low-quality generics
Patients in India, especially the poor with limited access to healthcare, are caught between the devil and the deep sea. They cannot afford the exorbitantly priced patented medicines offered by global ‘big pharma.’ For that matter, even most people in prosperous countries
